Table 1 Clinical and 2-D echocardiographic findings in all patients (n = 100)
Characteristics | CHF (n = 50) | CS (n = 50) | p-value |
|---|---|---|---|
Age (y) | 57 ± 13 | 58 ± 10 | 0.88 |
Male Gender (%) | 30 (60) | 29 (58) | 1.00 |
Diabetes mellitus (%) | 30 (60) | 32 (64) | 0.90 |
Hypertension (%) | 35 (70) | 37 (74) | 0.78 |
Dyslipidemia (%) | 25 (50) | 23 (46) | 0.90 |
Smoking history (%) | 34 (68) | 32 (64) | 0.82 |
Cardiac medications | |||
Beta blockers (%) | 50 (100) | 10 (20) | < 0.05 |
ACE inhibitors (%) | 48 (96) | 5 (10) | < 0.05 |
Digoxin (%) | 25 (50) | 5 (10) | < 0.05 |
Spironolactone (%) | 32 (64) | 0 (0) | < 0.05 |
Inotropic support (%) | 0 (0) | 50 (100) | < 0.05 |
Left Heart Dimensions | |||
IVS (mm) | 10 ± 2 | 11 ± 2 | 0.87 |
PWT (mm) | 11 ± 2 | 11 ± 1 | 0.90 |
LVEDD (mm) | 60 ± 2 | 59 ± 3 | 0.85 |
EF (%) | 25 ± 6 | 23 ± 7 | 0.82 |